CORE LABORATORIES NV's gross profit margin for the first quarter of its fiscal year 2016 has decreased when compared to the same period a year ago. Sales and net income fell significantly, but still managed to outperform when compared to the average company in its industry. CORE LABORATORIES NV has average liquidity. Currently, the Quick Ratio is 1.35 which shows that technically this company has the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has significantly decreased by 226.05% from the same quarter last year. Together, the key liquidity measurements indicate that it is relatively unlikely that the company will face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY16||Q1 FY15|
|Net Sales ($mil)||153.65||213.64|
|Net Income ($mil)||15.08||31.4|
|Balance Sheet||Q1 FY16||Q1 FY15|
|Cash & Equiv. ($mil)||16.67||19.14|
|Total Assets ($mil)||587.25||630.01|
|Total Debt ($mil)||408.52||373.0|
|Profitability||Q1 FY16||Q1 FY15|
|Gross Profit Margin||26.58||32.47|
|Return on Assets||16.77||36.16|
|Return on Equity||0.0||860.28|
|Debt||Q1 FY16||Q1 FY15|
|Share Data||Q1 FY16||Q1 FY15|
|Shares outstanding (mil)||42.39||42.98|
|Div / share||0.55||0.55|
|Book value / share||-0.79||0.62|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||705374.0||666838.0|
HOLD. This stock's P/E ratio indicates a premium compared to an average of 53.94 for the Energy Equipment & Services industry and a significant premium compared to the S&P 500 average of 23.99. Normally, for additional comaprison, we would look at the price-to-book ratio; however, this company's price-to-book ratio is negative making the value useless for comparisons. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, CORE LABORATORIES NV seems to be trading at a premium to investment alternatives within the industry.
|CLB 57.29||Peers 53.94||CLB 29.91||Peers 10.89|
Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.
CLB is trading at a valuation on par with its peers.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CLB is trading at a significant premium to its peers.
|CLB 55.83||Peers 114.69||CLB NM||Peers 0.13|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
CLB is trading at a significant discount to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CLB's negative PEG ratio makes this valuation measure meaningless.
|CLB NM||Peers 1.97||CLB -55.34||Peers -128.48|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CLB's P/B is negative making this valuation measure meaningless.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
CLB is expected to have an earnings growth rate that significantly exceeds its peers.
|CLB 7.57||Peers 2.35||CLB -28.81||Peers -31.84|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CLB is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
CLB significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.